Assessing TGF-β Prognostic Model Predictions for Chemotherapy Response and Oncogenic Role of FKBP1A in Liver Cancer
Our study highlights the potential of TGFBRS in predicting chemotherapy responses and in shaping the tumor immune microenvironment in liver cancer. The results identify FKBP1A as a promising molecular target for developing preventive and therapeutic strategies against liver cancer. Our findings could potentially guide personalized treatment strategies to improve the prognosis of liver cancer patients.
Authors
- Weimei Chen
- Qingshui Wang (ORCID: https://orcid.org/0000-0002-1714-1737)
- Lin Zhou (ORCID: https://orcid.org/0000-0003-0265-9776)
- Rongrong Zhong
- Qinghe Que
- Qiaolan Yi
Institutions
- Fujian University of Traditional Chinese Medicine (CN)
- Fujian Medical University (CN)
- First Affiliated Hospital of Fujian Medical University (CN)
Publication Details
- Journal
- Current Pharmaceutical Design
- Published
- 2024-08-26
- DOI
- https://doi.org/10.2174/0113816128326151240820105525
- Citations
- 4
- Primary Topic
- Endoplasmic Reticulum Stress and Disease
- Type
- article
- Field-Weighted Citation Impact
- 1.30